ABSTRACT
Re-expansion pulmonary edema (REPE) is an uncommon complication following re-expansion of the lung as treatment of conditions such as hemopneumothorax, large pleural effusion, and after lobectomy, pneumothorax, or even during single-lung ventilation. The majority of REPE complications are associated with treatment of spontaneous pneumothorax. The etiology of REPE remains speculative, although it is thought to be caused by increased pulmonary capillary permeability. Risk factors, including young age, a large pneumothorax, and long duration of collapse, may help predict the patients that might encounter this complication.
Subject(s)
Pulmonary Edema/etiology , Thoracostomy/adverse effects , Adult , Humans , Male , Pneumothorax/surgery , Pulmonary Atelectasis/surgeryABSTRACT
AIM: To assess the efficacy of pleural tenting in patients with complicated primary spontaneous pneumothorax (PSP). METHODS: From 1988 through 2001, 43 patients underwent operations. Mean age was 30.4 years; the male/female ratio was 9.7. Twenty-one (48.8%) underwent pleural tenting in addition to bulla excision (experimental group, EG). Twenty-two (51.2%) underwent bulla excision plus pleural abrasion (11 patients), apical partial pleurectomy (9 patients) and complete apical pleurectomy (2 patients) (control group, CG). The most frequent symptom was chest pain (37.2%). Surgical indications were recurrence in 21 (48.8%), prolonged air leak in 12 (27.9%), failure of expansion without air leak in 6 (13.9%), high risk occupancy in 2 (4.6%) and empyema due to air leak in 2 (4.6%). RESULTS: Air leak time was decreased by tenting (1.9 days vs 3.7 days) as well as time of drainage (4.8 vs 6.9) and hospital stay (5.8 vs 7.9). Morbidity was 9.5% in EG and 9.1% in CG. Causes of morbidity were postoperative hematoma, prolonged air leak, expansion failure and blunt posterior sinus one of each. Re-operation needed for postoperative hematoma in CG. Mean follow-up was 5.1 years and 1 (4.5%) recurrence observed in CG. CONCLUSION: Tenting of the dependent lung from the apical pleura after bullectomy via axillary thoracotomy lessens air leak time without recurrence and low morbidity.
Subject(s)
Pleura/surgery , Pneumonectomy/methods , Pneumothorax/surgery , Surgical Flaps , Adolescent , Adult , Chest Pain/etiology , Chest Tubes , Drainage , Dyspnea/etiology , Empyema/etiology , Female , Follow-Up Studies , Hematoma/etiology , Humans , Length of Stay/statistics & numerical data , Male , Patient Selection , Pneumonectomy/adverse effects , Pneumothorax/diagnosis , Pneumothorax/etiology , Recurrence , Reoperation/statistics & numerical data , Risk Factors , Tachycardia/etiology , Time Factors , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
BACKGROUND AND OBJECTIVES: Management of malignant pleural mesothelioma (MPM) has been an important clinical issue regardless of the treatment modality employed. We aimed to investigate the efficacy of oxytetracycline (OT), Corynebacterium parvum (CP), and nitrogen mustard (NM) in the management of pleural effusion associated with MPM. METHODS: One hundred and seventeen patients who had stage-2 MPM or over according to the Butchart staging system and unilateral or bilateral pleural effusion took part in the study. The patients received either OT (35 mg/kg), CP (7 mg), or NM (0.4 mg/kg) through a chest tube for pleurodesis. The association between several clinical parameters and patient survival was also investigated. RESULTS: OT was applied to 59, CP to 29 and NM to 29 cases. A statistical analysis of the results obtained by these agents have demonstrated that OT (30 days, 81%; 90 days, 76.2%) and CP (30 days, 86.2%; 90 days, 79.3%) led to a significantly higher rate of successful pleurodesis as compared to NM (30 days, 48.2%; 90 days, 41.3%; p <0.05). Although the procedure was generally well tolerated by the patients, the NM-treated group experienced significantly more nausea-vomiting (46.1%) and hypotension (35.8%) compared to patients who received OT (nausea-vomiting and hypotension 4.3%; p < 0.001) and CP (nausea-vomiting and hypotension 5.1%; p < 0.001). Furthermore, we found that thrombocytosis, chest pain and weight loss were significantly associated with poor prognosis, whereas epithelial type had a positive effect on survival. CONCLUSION: These results suggest that OT and CP may be used as effective sclerosing agents for pleurodesis in the control of pleural effusions associated with MPM, without major side effects.
Subject(s)
Mechlorethamine/administration & dosage , Mesothelioma/therapy , Oxytetracycline/administration & dosage , Pleural Effusion, Malignant/therapy , Pleurodesis , Propionibacterium acnes , Sclerosing Solutions/administration & dosage , Adult , Aged , Asbestos/adverse effects , Chest Tubes/adverse effects , Environmental Exposure/adverse effects , Female , Humans , Male , Mesothelioma/etiology , Mesothelioma/mortality , Mesothelioma/pathology , Middle Aged , Neoplasm Staging , Pleural Effusion, Malignant/etiology , Pleural Effusion, Malignant/mortality , Pleural Effusion, Malignant/pathology , Pleurodesis/methods , Sclerosing Solutions/adverse effects , Survival Analysis , Thoracostomy , Treatment Outcome , Turkey/epidemiologyABSTRACT
Sixteen patients were treated for traumatic oesophageal perforation (13 cervical, 3 thoracic) over a 16-year period. In 14 cases the trauma was penetrating. The median delay from injury to treatment was 32 hours and the mean period of hospitalization was 26 days. The treatment procedures were two-layer primary closure with or without drainage, drainage alone and near-total oesophageal exclusion with cervical T-tube oesophagostomy. Postoperative complications were cervical oesophageal leak in two patients and tracheo-oesophageal fistula and oesophageal stenosis, each in one case. Of the eight patients treated within 24 hours of perforation, two died, and of the eight treated later, four died (overall mortality 37.5%). The heightened mortality after delayed diagnosis illustrates the prognostic importance of a high index of suspicion. To prevent leakage, buttressing with viable tissue following primary closure can be useful, especially after delayed diagnosis. Because of the continuing controversy concerning management of late-diagnosed oesophageal perforation, individualized treatment is widely advocated.
Subject(s)
Esophageal Perforation/surgery , Wounds, Gunshot/surgery , Wounds, Nonpenetrating/surgery , Adolescent , Adult , Child , Esophageal Perforation/diagnosis , Esophageal Perforation/mortality , Female , Follow-Up Studies , Humans , Male , Postoperative Complications , Prognosis , Survival Rate , Wounds, Gunshot/diagnosis , Wounds, Gunshot/mortality , Wounds, Nonpenetrating/diagnosis , Wounds, Nonpenetrating/mortalityABSTRACT
Early pulmonary decortication was performed on 66 of 137 children with postpneumonic empyema, while 71 received conventional treatment. The mean age of the 66 patients with decortication was 5.5 years (range 6 months-14 years). The empyema was left-sided in 34 and right-sided in 32. Decortication was performed when lung expansion was not obtained after 10-12 days of intercostal tube drainage, antibiotic therapy (guided by sensitivity tests of pleural fluid) and pleural irrigation. Scintigraphy showed loss of pulmonary perfusion on the side of empyema to be 65% +/- SD 20 (25-98)% before decortication in the 23 tested patients. In ten of them the test was repeated after surgery and showed significant (p < 0.001) diminution of the perfusion defect, from 57 +/- 6.8 (25-84)% to 4 +/- 2.6 (0-8)%. The hospital stay was significantly (p < 0.001) shorter for the surgically treated than for the classically managed patients, viz. 19.5 +/- 4 (13-36) days vs 73.6 +/- 14 (34-110) days. Early decortication thus had beneficial effects on pulmonary perfusion and hospital stay.
